CLLS — Cellectis S.A.

—
Nasdaq · Health Care · Biotechnology · CIK 1627281 · France
Last close
$1.06
Market Cap
$77.08M
52W High
$5.45
52W Low
$0.88
ADV30
94,181
Next earnings
2026-11-12

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 3,764,000 1,271,000 -66,918,000 -61,474,000 213,425,000 28,229,000 231,057,000
Jun 2026 5,229,000 2,874,000 -23,520,000 -21,819,000 267,365,000 35,590,000 226,298,000
Mar 2026 5,777,000 3,457,000 -25,168,000 -17,765,000 289,187,000 34,841,000 229,267,000
Dec 2025 10,396,000 7,397,000 -17,351,000 -26,318,000 324,720,000 61,533,000 248,819,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-41,627,000
Investing CF
$31,558,000
Financing CF
$-16,553,000
CapEx
$-3,351,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-0.65
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-303,928,000
Inventory
—
Receivables
$13,644,000
ST Investments
$131,257,000
EBIT TTM
$-57,583,000
Pretax Income TTM
$-65,665,000
Interest Exp TTM
$8,082,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$63,823,000
EBITDA
$-46,677,000
Free Cash Flow
$107,701,376
Enterprise Value
$139,028,288
Total Cash
$166,686,000
Total Debt
$80,350,000
Shares Out
72,718,974
Trailing EPS
$-0.64
Book Value
$0.56
ROE
-94.5%
ROA
-11.7%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 72,949,000 -33,076,000 -67,593,000 324,720,000 248,819,000 75,901,000 -39,401,000
Dec 2024 41,506,000 -59,554,000 -36,761,000 383,544,000 252,511,000 131,033,000 22,989,000
Dec 2023 755,000 -97,303,000 -101,059,000 334,270,000 249,575,000 84,695,000 -24,746,000
Dec 2022 19,171,000 -89,666,000 -106,139,000 261,216,000 135,275,000 117,968,000 -87,444,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.62

Peers — same industry

TickerNameMarket CapLastDaily %
CHRS Coherus Oncology, Inc. $73.95M $0.48 —
TNYA Tenaya Therapeutics, Inc. $73.58M $0.32 —
BDTX Black Diamond Therapeutics, Inc. $82.75M $1.44 —
VXRT Vaxart, Inc. $86.51M $0.35 —
AVXL ANAVEX LIFE SCIENCES CORP. $68.60M $0.74 —

News headlines (Yahoo Finance, 1h cache)

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene Editing ...
2026-11-13 23:03 · Yahoo
What Cellectis (CLLS) Said on Its Q3 Earnings Call
2026-11-13 15:14 · Yahoo
Cellectis Reports Third Quarter 2026 Financial Results and Provides a Business Update
2026-11-13 00:24 · Yahoo
Cellectis to Report Third Quarter Financial Results on November 12, 2026
2026-11-09 21:30 · Yahoo
European Equities Traded in the US as American Depositary Receipts Decline Slightly in Tuesday Trading
2026-11-03 16:23 · Yahoo
Cellectis Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with .HEAL-101 at ESGCT 2026
2026-10-27 07:15 · Yahoo
European Equities Traded in the US as American Depositary Receipts Tumble in Tuesday Trading
2026-11-17 16:20 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise Marginally in Friday Trading
2026-11-13 16:17 · Yahoo
European Equities Traded in the US as ADRs Tick Higher in Wednesday Trading
2026-11-11 16:12 · Yahoo
Monthly information on share capital and company voting rights
2026-11-04 21:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.